Cylatron (peginterferon alfa-2b)
- Region
- 🇪🇺 EU
- Active substance
- peginterferon alfa-2b
- Company
- SP Europe
- Status
- Application withdrawn
- Therapeutic area
- Melanoma
- Application
- EMEA/H/C/000921
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Besremi Authorised · AOP Orphan Pharmaceuticals GmbH
- 🇪🇺 PegIntron Withdrawn · Merck Sharp & Dohme B.V.
- 🇪🇺 ViraferonPeg Withdrawn · Merck Sharp Dohme Ltd
Follow Cylatron
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.